MAC
68
-2
ALL
57
-3
MDT
53
-2
LYB
23
3
GS
75
-3
AXP
71
-2
SPG
51
-2
CAT
69
11
MHK
52
2
BDX
61
2
DOV
71
10
GWW
62
-3
UNP
36
-3
PSA
35
-2
PVH
32
2
MCD
42
-4
AAL
48
-2
MTCH
66
-5
STI
11
-4
RHI
38
3
MAC
68
-2
ALL
57
-3
MDT
53
-2
LYB
23
3
GS
75
-3
AXP
71
-2
SPG
51
-2
CAT
69
11
MHK
52
2
BDX
61
2
DOV
71
10
GWW
62
-3
UNP
36
-3
PSA
35
-2
PVH
32
2
MCD
42
-4
AAL
48
-2
MTCH
66
-5
STI
11
-4
RHI
38
3
Financhill
Back

Connect Biopharma Holdings Ltd. 10K Form

Buy
69

CNTB
Connect Biopharma Holdings Ltd.

Last Price:
$2.67
Seasonality Move:
18.52%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive CNTB News And Ratings

See the #1 stock for the next 7 days that we like better than CNTB

CNTB Financial Statistics

Sales & Book Value

Annual Sales: $26M
Cash Flow: $-10M
Price / Cash Flow: 0
Annual Sales: $1.50
Price / Book: 2.72

Profitability

EPS (TTM): -0.39000
Net Income (TTM): $-21.4M
Gross Margin: $25.4M
Return on Equity: 0%
Return on Assets: 0%

Connect Biopharma Holdings Ltd. Earnings Forecast

Key Connect Biopharma Holdings Ltd. Financial Ratios

  • The Gross Profit Margin over the past 7 years for CNTB is 97.46%.
  • The Selling, General & Administrative Expenses for CNTB have been equal to 73.86% of Gross Profit Margin.
  • The Research & Development expenses have been 112.38% of Revenue.
  • The Net Earning history of CNTB is -60.03% of Total Revenues.
  • Per Share Earnings over the last 7 years have been positive in 3 years.

Connect Biopharma Holdings Ltd. Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: CNTB
Website: connectbiopharm.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 12.04
Quick Ratio: 11.85

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

CNTB Technical Analysis vs Fundamental Analysis

Buy
69
Connect Biopharma Holdings Ltd. (CNTB) is a Buy

Is Connect Biopharma Holdings Ltd. a Buy or a Sell?